GlobalData PLC
DATA
ISIN GB00BR3VDF43 / Valor 128270450
GlobalData PLC
UMushroom community rating:
About company
GlobalData PLC is a comprehensive business intelligence provider that operates across various sectors including healthcare, construction, infrastructure, financial services, automotive, and agribusiness. The company offers a range of services such as actionable leads and contacts for the Pharma and biotechnology industries through Infinata, and market and sector intelligence via Timetric. Progressive Digital Media enhances client-customer interactions through numerous annual events and online affiliate marketing services. Sociable Pharma delivers tailored research and analysis services throughout the pharmaceutical and biotech product lifecycle. Additionally, LMCA Holdings Ltd. and LMCI Holdings Ltd. contribute data and insights in the automotive and agribusiness markets, respectively. TS Lombard, another subsidiary, provides independent economic and investment strategy research, leveraging its understanding of global economic interactions to project economic performance. Through these diverse offerings, GlobalData PLC equips its clients with high-quality, actionable intelligence to support strategic decision-making.
Summarized from source with an LLMView SourceSector: TechnologyLatest Results (15.04.2026):
GlobalData PLC — Q4 2025 (year ended 31 December 2025): The company posted modest underlying revenue growth but weaker profitability and a significant swing to net debt. Underlying revenue rose 1% (13% reported) while adjusted EBITDA fell 6% to £110.2m and margin dropped to 34%. Profit before tax improved to £69.2m, helped by non‑cash items, but cash from operations and operating margins weakened and net (bank debt)/cash moved to (£114.2m) at year end.
Revenue performance
Group underlying revenue growth was 1% for the year (13% reported growth), indicating organic stability but with reported growth boosted by acquisitions or FX.
Adjusted EBITDA and margin
Adjusted EBITDA declined 6% year‑on‑year to £110.2m and the adjusted EBITDA margin fell to 34% from 41% in 2024, showing pressure on operating profitability.
Profit before tax and non‑cash items
Profit before tax increased to £69.2m (2024: £54.9m). This includes a £15.4m non‑cash share‑based payments credit and £12.1m charge for amortisation of acquired intangibles, which materially affect comparability.
Basic earnings per share
Basic EPS rose to 4.4p (2024: 3.8p), reflecting the higher reported profit partly driven by the non‑cash adjustments noted above.
Cash from operations
Cash generated from operations decreased to £83.3m (2024: £97.6m), signaling lower operating cash conversion versus the prior year.
Balance sheet / net (bank debt)/cash
Net (bank debt)/cash moved to (£114.2m) at 31 December 2025 from net cash of £10.1m a year earlier — a significant swing to net debt that will affect flexibility and financing costs.
Contracted forward revenue
Contracted forward revenue showed underlying growth of 3% (5% reported), offering some visibility of future revenue despite modest organic growth.
Dividend
The board proposed a final dividend of 1.2p per share (2024: 1.0p), a small increase that signals continued shareholder returns despite margin and cash pressures.
Summarized from source with an LLMView SourceKey figures
Performance
Volatility
994 M
Market cap (USD)
1,267,609
Daily traded volume (Shares)
1.88 / 1.835
1 day high/low (USD)
52 weeks high/low (USD)
Dividend ex-date
Dividend (USD)
Dividend yield (p.a.)
Est dividend (USD)
Est dividend yield
P/E ratio
Est P/E ratio
EPS (USD)
Est EPS (USD)
Ratings & reviews
EQUITIES OF THE SAME SECTOR
